Low-dose apixaban comparable to full dose for preventing venous thromboembolism recurrence in patients with cancer
Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning ...
MyChesCo on MSN14h
FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...